News Karnataka
Thursday, November 30 2023
Health & Lifestyle

US experimental HIV vaccine regimen safe but ineffective: Study

Photo Credit : IANS

Los Angeles: A US investigational HIV vaccine regimen was safe but did not provide protection against HIV acquisition, according to a statement of the US National Institute of Health (NIH).

The trial, called HPX3002/HVTN 706 or “Mosaico,” began in 2019 and involved 3,900 volunteers aged between 18 to 60 years in Europe, North America and South America, Xinhua news agency reported.

The trial was conducted by the HIV Vaccine Clinical Trials Network funded by the US National Institute of Allergy and Infectious Diseases, based at the Fred Hutchinson Cancer Research Centre in Seattle.

The experimental vaccine regimen was developed by Janssen. It was based on “mosaic” immunogens — vaccine components featuring elements of multiple HIV subtypes — with the goal of inducing immune responses against a wide variety of global HIV strains, according to the NIH on Wednesday.

Share this:
Support NewsKarnataka's quality independent journalism with a small contribution.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Editor's Pick

Find the best odds at 10Cric and IPL Betting 2023! Signup today and get up to a 100% deposit bonus.

To get the latest news on WhatsApp